Gene · 8454
Papers4,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevity. | Nat Commun | 2023 | 37891180 | PubTator, text mining | PubMed |
| Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota. | Front Med (Lausanne) | 2023 | 37881635 | PubTator, text mining | PubMed |
| USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7. | PLoS One | 2023 | 37874827 | PubTator, text mining | PubMed |
| Catalysis of non-canonical protein ubiquitylation by the ARIH1 ubiquitin ligase. | Biochem J | 2023 | 37870100 | PubTator, text mining | PubMed |
| An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses. | J Biol Chem | 2023 | 37865315 | PubTator, text mining | PubMed |
| Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein. | Virol J | 2023 | 37853388 | PubTator, text mining | PubMed |
| EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail. | Cancer Lett | 2023 | 37838280 | PubTator, text mining | PubMed |
Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-boxFBXO11 -mediated heterogeneous nuclear ribonucleoprotein A2/B1 ubiquitination and promote hepatocellular carcinoma. | Clin Transl Med | 2023 | 37837399 | PubTator, text mining | PubMed |
| A noncanonical function of SKP1 regulates the switch between autophagy and unconventional secretion. | Sci Adv | 2023 | 37831778 | PubTator, text mining | PubMed |
| FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing. | Adv Sci (Weinh) | 2023 | 37822160 | PubTator, text mining | PubMed |
| The herpesvirus UL49.5 protein hijacks a cellular C-degron pathway to drive TAP transporter degradation. | bioRxiv | 2023 | 37808699 | PubTator, text mining | PubMed |
| Proliferation-associated 2G4 P48 is stabilized by malignant T-cell amplified sequence 1 and promotes the proliferation of head and neck squamous cell carcinoma. | J Dent Sci | 2023 | 37799877 | PubTator, text mining | PubMed |
| The role of E3 ubiquitin ligases in bone homeostasis and related diseases. | Acta Pharm Sin B | 2023 | 37799379 | PubTator, text mining | PubMed |
| The novel β-TrCP protein isoform hidden in circular RNA confers trastuzumab resistance in HER2-positive breast cancer. | Redox Biol | 2023 | 37783059 | PubTator, text mining | PubMed |
| Synergy between a cytoplasmic vWFA/VIT protein and a WD40-repeat F-box protein controls development in Dictyostelium. | Front Cell Dev Biol | 2023 | 37779900 | PubTator, text mining | PubMed |
| Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases. | Exp Mol Med | 2023 | 37779139 | PubTator, text mining | PubMed |
| Role of non-canonical post-translational modifications in gastrointestinal tumors. | Cancer Cell Int | 2023 | 37777749 | PubTator, text mining | PubMed |
| KDM2B regulates inflammation and oxidative stress of sepsis via targeting NF-κB and AP-1 pathways. | Immun Inflamm Dis | 2023 | 37773725 | PubTator, text mining | PubMed |
| MicroRNA-25/93 induction by Vpu as a mechanism for counteracting MARCH1-restriction on HIV-1 infectivity in macrophages. | mBio | 2023 | 37773002 | PubTator, text mining | PubMed |
| Targeting cullin neddylation for cancer and fibrotic diseases. | Theranostics | 2023 | 37771770 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8454/papers?page=13